Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy

2007 Universal Myocardial Infarction Definition Change Criteria for Risk Stratification by Use of a High-Sensitivity Cardiac Troponin I Assay

(2010) P. A. Kavsak et al.   CLINICAL CHEMISTRY

Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure

(2009) Lutz Frankenstein et al.   BASIC RESEARCH IN CARDIOLOGY

Variability of N-Terminal Probrain Natriuretic Peptide in Stable Chronic Heart Failure and Its Relation to Changes in Clinical Variables

(2009) L. Frankenstein et al.   CLINICAL CHEMISTRY

Role of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for Early Diagnosis of Myocardial Infarction and Prediction of Risk of Adverse Events

(2009) F. S. Apple et al.   CLINICAL CHEMISTRY

Minor troponin T elevation in patients 6 months after acute myocardial infarction: an observational study

(2009) Mirja Neizel et al.   Clinical Research in Cardiology

Short- and Long-Term Biological Variation in Cardiac Troponin I Measured with a High-Sensitivity Assay: Implications for Clinical Practice

(2008) A. H.B. Wu et al.   CLINICAL CHEMISTRY

Highly Sensitive Cardiac Troponin T Values Remain Constant after Brief Exercise- or Pharmacologic-Induced Reversible Myocardial Ischemia

(2008) K. Kurz et al.   CLINICAL CHEMISTRY

The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST

(2008) Yukihito Sato et al.   Journal of Cardiology

The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing

(2007) Alan H.B. Wu et al.   AMERICAN HEART JOURNAL